Judge Finds for Wyeth, Schwarz on Reglan/Metoclopramide Injury Claims

LAKE CHARLES, La. - Two Reglan manufacturers cannot be held liable to a plaintiff who was allegedly injured by ingesting the drug's generic equivalent, a Louisiana federal judge has ruled. Johnson v. Teva Pharmaceuticals USA Inc., No. 10-404 (W.D. La.).

Louisiana state and federal courts have made it clear that brand name drug manufacturers do not owe a continuing duty to consumers of the generic drug equivalent, Judge Patricia Minaldi of the U.S. District Court for the Western District of Louisiana ruled Aug. 16.

Tina Johnson sued Wyeth LLC, Schwarz Pharma Inc., Alaven Pharmaceutals Inc., Qualitest Inc. and Teva Pharmaceuticals …